From Bridgewater to Mumbai, our global network connects research, manufacturing, and commercial offices across the U.S., Ireland, and India—empowering us to deliver high-quality medicines efficiently and responsibly, wherever patients need them most.
We have one of the largest U.S.-based manufacturing footprints in the industry. We believe a more resilient pharmaceutical supply chain is essential to America’s health security—and we’re actively building it.
US Home(Opens in a new window) US Careers(Opens in a new window)
6 facilities
~2,500 total employees
6 facilities
since
2002
Our state-of-the-art operations in India are an integral part of our global R&D and manufacturing network, supporting the commercialization of our products in the U.S. We also maintain active pharmaceutical ingredient (API) operations, enabling full vertical integration across a significant portion of our portfolio.
India Home(Opens in a new window) India Careers(Opens in a new window)
~5,500
total employees
8 facilities
~5,500
total employees
since
2008
Amneal Ireland Limited is focused on producing metered-dose and dry-powder inhalers. Ireland offers established infrastructure, highly skilled workforce, supportive government, and a strong business environment that drives innovation—and Amneal is proud to build on that foundation.
Specializing in inhalation
107 total employees
Specializing in inhalation
since
2015
Corporate
India